Will Teva's (TEVA) Extended Sustainability-Linked Credit Line Reshape Its Balance Sheet and Risk Narrative? [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
facility to April 29, 2028, while easing certain leverage and interest coverage covenants and providing flexibility tied to potential future investment-grade status. This extension, alongside progress in higher-margin branded and biosimilar products and growing institutional interest, underscores Teva's efforts to strengthen its balance sheet and reposition its business mix toward more resilient earnings streams. We'll now explore how the revolving credit extension and greater financial flexibility might influence Teva's existing investment narrative and risk profile. Find companies with promising cash flow potential yet trading below their fair value To own Teva today, you need to believe it can keep shifting from low growth generics to higher margin branded and biosimilar products while managing a still heavy debt load. The revolving credit extension modestly reduces near term refinancing risk, but does not change the key short term catalyst around execution in branded launc
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries (NYSE:TEVA) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=TEVA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat"MarketBeat
- Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026 [Yahoo! Finance]Yahoo! Finance
- Teva Releases Q4 2025 Aide Memoire [Yahoo! Finance]Yahoo! Finance
- Teva Releases Q4 2025 Aide MemoireGlobeNewswire
TEVA
Earnings
- 11/5/25 - Beat
TEVA
Sec Filings
- 12/12/25 - Form 144
- 12/11/25 - Form 8-K
- 12/11/25 - Form 4
- TEVA's page on the SEC website